Your kidneys play a surprisingly large role in blood sugar regulation. Far from just filtering waste, they actively produce glucose, reabsorb it from urine, clear insulin from your bloodstream, and even send nerve signals to your brain that influence how much glucose your body makes. When kidney function declines, blood sugar control can shift dramatically in both directions.
Kidneys Produce Their Own Glucose
Most people think of the liver as the body’s glucose factory, but the kidneys are the second most important organ for making new glucose from scratch. After a meal has been fully absorbed (the “post-absorptive” phase), your kidneys generate up to 28% of the glucose circulating in your blood. Under stress, during prolonged fasting, or when your body becomes more acidic, that contribution rises to 40 to 50%.
This matters because it means your kidneys aren’t passive bystanders in blood sugar balance. They’re actively pumping glucose into your bloodstream to keep your brain and muscles fueled, especially between meals and overnight. If kidney function drops, this glucose-producing capacity drops too, which is one reason people with advanced kidney disease can experience unexpected low blood sugar episodes.
How Your Kidneys Recycle Glucose
Every day, your kidneys filter roughly 180 grams of glucose out of your blood. That’s about 720 calories’ worth. Under normal circumstances, nearly all of it gets reabsorbed back into the bloodstream before it reaches your bladder. Specialized transport proteins in the first part of the kidney’s filtering tubes do the heavy lifting, recapturing about 90% of filtered glucose. A second set of transporters in a later segment mops up most of the rest.
This system has a ceiling, though. When blood sugar rises above roughly 180 mg/dL, the transporters become saturated and can’t keep up. Glucose spills into the urine. This threshold (called the renal threshold for glucose) varies from person to person. In people with diabetes, it can range widely, from as low as 54 mg/dL to as high as 300 mg/dL. A study of 65 people with insulin-dependent diabetes found an average threshold of 130 mg/dL. That variability helps explain why two people with the same blood sugar reading can have very different urine glucose results.
A Nerve Connection Between Kidneys and Brain
Research published in eLife revealed something striking: when mice lost extra glucose in their urine, nerve fibers running from the kidneys to the brain’s hypothalamus triggered a stress response that ramped up glucose production elsewhere in the body. The kidneys essentially sensed the glucose loss as a threat and told the brain to compensate. When researchers severed those nerve connections, fasting and fed blood sugar levels dropped by about 50%, and the stress hormone response reversed.
This kidney-to-brain signaling pathway suggests the kidneys act as glucose sensors, not just glucose handlers. While this research is in mice, it offers a biological explanation for why blocking glucose reabsorption in the kidneys (the mechanism behind a class of diabetes medications) triggers the body to try making more glucose on its own.
Kidneys Control How Long Insulin Stays Active
Your kidneys are also responsible for clearing insulin from the blood. The liver removes about 40 to 50% of insulin on its first pass from the pancreas, but the kidneys handle a significant share of what remains. About 60% of renal insulin clearance happens through normal filtration, while the other 40% is pulled directly from blood vessels surrounding the kidney tissue.
For people who inject insulin, the kidneys become even more important. Exogenous insulin bypasses the liver’s first-pass extraction, so the kidneys end up metabolizing 30 to 80% of injected insulin. This has real consequences: as kidney function declines, insulin lingers in the bloodstream longer, and its blood-sugar-lowering effect intensifies. People with diabetes and worsening kidney disease often notice a characteristic pattern. Early on, insulin resistance increases and they need higher doses. But once kidney filtration drops below about 20 mL/min, insulin clearance slows so much that the same dose can cause dangerously low blood sugar. Doses often need to be reduced significantly at that stage.
How Kidney Disease Disrupts Blood Sugar
Chronic kidney disease creates a complex tug-of-war with blood sugar. On one side, waste products that healthy kidneys would normally remove build up in the blood and interfere with how muscles respond to insulin. These uremic toxins cause fat to redistribute into muscle and liver tissue, trigger inflammation, and directly block insulin’s signaling pathway inside cells. The result is insulin resistance: your body needs more insulin to move the same amount of glucose out of the bloodstream.
On the other side, advanced kidney disease increases the risk of hypoglycemia through multiple overlapping mechanisms:
- Reduced glucose production: damaged kidneys make less new glucose
- Slower insulin clearance: insulin and diabetes medications stay active longer
- Impaired counter-regulatory hormones: the hormones that normally raise blood sugar in response to a low (like glucagon, cortisol, and growth hormone) don’t respond as strongly
- Muscle wasting and poor nutrition: reduced glycogen stores and calorie intake leave less reserve to draw on
- Uremic toxin accumulation: some waste products have their own glucose-lowering effects
This combination explains a phenomenon sometimes called “burnt-out diabetes,” where people who once needed high doses of insulin or medication find their blood sugar dropping on its own as kidney disease progresses. It’s not that the diabetes has resolved. The kidneys’ declining function has shifted the balance in the opposite direction.
Medications That Target Kidney Glucose Handling
SGLT2 inhibitors are a class of diabetes medication that work entirely through the kidneys. They block the main glucose transporter in the kidney’s filtering tubes, reducing glucose reabsorption by 30 to 60% and lowering the threshold at which glucose spills into urine. The excess glucose leaves the body through urination, producing an average A1c reduction of 0.5 to 1.0 percentage points.
These medications have become important beyond blood sugar control. Current guidelines from the American Diabetes Association recommend them for people with diabetes who have reduced kidney filtration or elevated protein in their urine, because they also slow the progression of kidney damage itself. GLP-1 receptor agonists, another class of diabetes medication, are now also recommended for kidney protection based on recent trial data. Both represent a shift in thinking: treating the kidney-glucose relationship isn’t just about managing blood sugar, it’s about preserving kidney function too.
What This Means for Blood Sugar Monitoring
If you have any degree of kidney impairment, blood sugar patterns can behave differently than you might expect. Insulin sensitivity changes as kidney function changes, sometimes in opposite directions at different stages. Medications may need dose adjustments not because they stop working, but because the kidneys process them differently. And blood sugar readings can swing more widely because the kidneys’ stabilizing role in glucose balance is compromised.
The renal threshold for glucose also means that urine glucose tests are unreliable as a proxy for blood sugar, particularly in people with diabetes, where that threshold can vary by more than 200 mg/dL from one person to the next. Blood-based monitoring gives a far more accurate picture of what’s actually happening.